Skip to content

Click here to return to the home page

SUPARTZ Technology

The technology behind Supartz Joint Fluid Therapy

Technology behind SUPARTZ Joint Fluid Therapy

Technology behind SUPARTZ Joint Fluid Therapy

SUPARTZ Joint Fluid Therapy is made of highly purified sodium hyaluronate (hyaluronan). Hyaluronan or hyaluronic acid is a natural chemical in the body and is found in particularly high amounts in joint tissues and in the fluid (synovial fluid) that fills joints. The body’s own hyaluronan acts like a lubricant and shock absorber in synovial fluid of a healthy joint. Osteoarthritis reduces your synovial fluid’s ability to protect and lubricate your joint.

SUPARTZ Joint Fluid Therapy is the most commonly used joint fluid therapy in the world.1 It is proven to be safe and highly effective. Moreover, it was the first hyaluronan in the world available commercially for human use in treating the pain of osteoarthritis.

In five clinical studies conducted, adverse effects occurred at similar rates in patients treated with SUPARTZ Joint Fluid Therapy and those treated with simple saltwater. The most common adverse effects were joint pain with no evidence of inflammation, joint pain with evidence of inflammation, back pain, non-specific pain, injection site reaction, headache and injection site pain.

The extensive worldwide clinical history of SUPARTZ Joint Fluid Therapy will give your physician the confidence that it will safely offer you relief from knee pain.

For more information about SUPARTZ Joint Fluid Therapy ask your doctor.

1. “Joint Ventures: Consumers Drive the Market for HA,” BioMaterials & Surgery, February 1999, pg.19.

SUPARTZ is a registered trademark of Seikagaku Corporation.